On this page you will find a repository of national and international guidance for health professionals on cancer management and COVID-19. The page has been updated to 09 July 2021 and is no longer being actively maintained. For advice specific to the health sector, please refer to the Department of Health and Aged Care's website.
[accordion]
Australia
The Royal Australian and New Zealand College of Radiologists (RANZCR)
Radiation Oncology Practice Guidance
Date: 27-Mar-2020
Audience: Radiation oncologists
Purpose: Resources to assist radiation oncology departments.
UK
Royal College of Radiologists (RCR)
Consensus Guidelines for the Management of Melanoma during the COVID-19 Pandemic: Surgery, Systemic Anti-cancer Therapy, Radiotherapy and Follow-up
Date: 01-Jul-2020
Audience: Radiation oncologists
Purpose: Guidance on management of melanoma cancer patients during the COVID-19 pandemic.
Royal College of Radiologists (RCR)
Managing treatment gaps in radiotherapy of lung cancer during the COVID-19 pandemic
Date: 06-May-2020
Audience: Radiation oncologists
Purpose: Guidance on radiotherapy for lung cancer patients during the COVID-19 pandemic.
Royal College of Radiologists (RCR)
Radiotherapy for melanoma in COVID-19 pandemic
Date: 05-May-2020
Audience: Radiation oncologists
Purpose: Guidance for management of melanoma patients during the COVID-19 pandemic.
Royal College of Radiologists (RCR)
Lower GI response to the COVID-19 outbreak
Date: 29-Apr-2020
Audience: Radiation oncologists
Purpose: Guidance for management of lower GI cancer patients during the COVID-19 pandemic.
Royal College of Radiologists (RCR)
Prioritisation of paediatric and TYA patients (with paediatric-type tumours) for radiotherapy during the COVID-19 pandemic
Date: 09-Apr-2020
Audience: Radiation oncologists
Purpose: Guidance to support paediatric cancer clinical teams to prioritise the provision of radiotherapy treatments for children, and teenagers and young adults (TYA) patients with paediatric-type tumours during the COVID-19 pandemic.
Royal College of Radiologists (RCR)
Guidance for the management of acute oncology patients during the coronavirus pandemic
Date: 07-Apr-2020
Audience: Radiation oncologists
Purpose: Guidance aims to clarify and support the continued provision of acute oncology services in light of the current COVID-19 pandemic.
Royal College of Radiologists (RCR)
Reduced fractionation in lung cancer patients treated with curative-intent radiotherapy during the COVID-19 pandemic
Date: 06-Apr-2020
Audience: Radiation oncologists
Purpose: Guidance on delivery of reduced-fractionation and curative-intent radiotherapy regimes for lung cancer patients during the COVID-19 pandemic.
Royal College of Radiologists (RCR)
Considerations for treatment of pancreatic cancer within the United Kingdom during the COVID-19 pandemic
Date: 03-Apr-2020
Audience: Radiation oncologists
Purpose: Guidance for management of pancreatic cancer patients during the COVID-19 pandemic.
Royal College of Radiologists (RCR)
Non-melanoma skin cancer (NMSC) and COVID-19
Date: 02-Apr-2020
Audience: Radiation oncologists
Purpose: Guidance for management of non-melanoma skin cancer patients during the COVID-19 pandemic.
Royal College of Radiologists (RCR)
Guidance for management of urothelial cancer during COVID-19 pandemic
Date: 01-Apr-2020
Audience: Radiation oncologists
Purpose: Guidance for management of urothelial cancer during the COVID-19 pandemic.
Royal College of Radiologists (RCR)
International guidelines on radiation therapy for breast cancer during the COVID-19 pandemic
Date: 31-Mar-2020
Audience: Radiation oncologists
Purpose: Guidance on radiation therapy for breast cancer patients during the COVID-19 pandemic.
Royal College of Radiologists (RCR)
Neuro-oncology treatment guidance during COVID-19 pandemic
Date: 27-Mar-2020
Audience: Radiation oncologists
Purpose: Guidance on how to manage neuro-oncology patients during the COVID-19 pandemic.
Royal College of Radiologists (RCR)
Head and neck cancer and COVID-19
Date: 25-Mar-2020
Audience: Radiation oncologists
Purpose: Guidance on radiation therapy for head and neck cancer patients during the COVID-19 pandemic.
Royal College of Radiologists (RCR)
Considerations for treatment of oesophagogastric cancers within the United Kingdom during the COVID-19 pandemic
Date: 25-Mar-2020
Audience: Radiation oncologists
Purpose: Guidance on radiation therapy for oesophagogastric cancer patients during the COVID-19 pandemic.
Royal College of Radiologists (RCR)
Guidance for treatment of uro-oncology patients during COVID-19 pandemic
Date: 24-Mar-2020
Audience: Radiation oncologists
Purpose: Guidance on radiation therapy for prostate cancer patients during the COVID-19 pandemic.
Royal College of Radiologists (RCR)
Thyroid cancer: radioactive iodine treatment during COVID-19 pandemic
Date: 24-Mar-2020
Audience: Radiation oncologists
Purpose: Guidance on radiation therapy for thyroid cancer patients during the COVID-19 pandemic.
Royal College of Radiologists (RCR)
Updated neoadjuvant/adjuvant/definitive radiotherapy guidelines for the management of newly diagnosed soft-tissue and bone sarcoma
Date: 24-Mar-2020
Audience: Radiation oncologists
Purpose: Guidance on radiation therapy for sarcoma patients during the COVID-19 pandemic.
Royal College of Radiologists (RCR)
Proposed guidance for radiotherapy for gynaecological cancer and COVID-19
Date: 24-Mar-2020
Audience: Radiation oncologists
Purpose: Guidance on radiation therapy for gynaecological cancer patients during the COVID-19 pandemic.
National Institute for Health and Care Excellence (NICE)
COVID-19 rapid guideline: Delivery of radiotherapy
Date: 28-Mar-2020
Audience: Health and care practitioners
Purpose: The purpose of this guideline is to maximise the safety of patients who need radiotherapy and make the best use of NHS resources, while protecting staff from infection. It will also enable services to match the capacity for radiotherapy to patient needs if services become limited because of the COVID-19 pandemic.
USA
European Society for Radiotherapy and Oncology (ESTRO)/ American Society for Radiation Oncology (ASTRO)
Practice recommendations for risk-adapted head and neck cancer radiotherapy during the COVID-19 pandemic: An ASTRO-ESTRO consensus statement
Date: 09-Apr-2020
Audience: Radiation oncologists
Purpose: Consensus recommendations on how to adapt radiotherapy for head and neck cancer in the COVID-19 pandemic.
European Society for Radiotherapy and Oncology (ESTRO)/ American Society for Radiation Oncology (ASTRO)
Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement
Date: 06-Apr-2020
Audience: Radiation oncologists
Purpose: Consensus recommendations on how to adapt radiotherapy for lung cancer in the COVID-19 pandemic.
John Hopkins Radiation Oncology Department
An Integrated program in a pandemic: John Hopkins radiation oncology department
Date: 30-Mar-2020
Audience: Radiation oncologists
Purpose: Guidance for staff from Johns Hopkins radiation oncology facilities in Maryland and the District of Columbia in response to COVID-19 pandemic.
American Society for Radiation Oncology (ASTRO)
COVID-19 recommendations and information summary
Date: 2020
Audience: Radiation oncologists
Purpose: Summary of recommendations and FAQs for radiation oncology practices.
Europe
Italian Association of Radiotherapy and Clinical Oncology (AIRO)
Head and neck radiotherapy amid the COVID-19 pandemic: Practice recommendations of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)
Date: 17-Aug-2020
Audience: Radiation oncologists
Purpose: Recommendations on how to manage patients with head and neck cancers in the pandemic and post-pandemic phase of the COVID-19 outbreak.
European Society of Paediatric Oncology (SIOPE) Radiation Oncology Working Group
Evidence-based recommendations from the SIOPE Radiation Oncology working group to help mitigate for reduced paediatric radiotherapy capacity during the COVID-19 pandemic
Date: 27-Apr-2020
Audience: Radiation oncologists
Purpose: Consensus recommendations on how to manage a shortage of paediatric radiotherapy facilities during the COVID-19 pandemic.
European Society for Radiotherapy and Oncology (ESTRO)/ American Society for Radiation Oncology (ASTRO)
Practice recommendations for risk-adapted head and neck cancer radiotherapy during the COVID-19 pandemic: An ASTRO-ESTRO consensus statement
Date: 09-Apr-2020
Audience: Radiation oncologists
Purpose: Consensus recommendations on how to adapt radiotherapy for head and neck cancer in the COVID-19 pandemic.
European Society for Radiotherapy and Oncology (ESTRO)/ American Society for Radiation Oncology (ASTRO)
Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement
Date: 06-Apr-2020
Audience: Radiation oncologists
Purpose: Consensus recommendations on how to adapt radiotherapy for lung cancer in the COVID-19 pandemic.
The European Society for Radiotherapy and Oncology (ESTRO)
COVID-19: Global radiation oncology’s targeted response for pandemic preparedness
Date: 24-Mar-2020
Audience: Radiation oncology community
Purpose: Advice on managing service continuity and discusses themes of infection prevention, rationalisation of workload and working practice in the presence of infection.
Marijnen et al., Radiotherapy and Oncology
International expert consensus statement regarding radiotherapy treatment options for rectal cancer during the COVID 19 pandemic
Date: 02-Apr-2020
Audience: Radiation oncologists
Purpose: Guidance on radiation therapy for rectal cancer patients during COVID-19 pandemic.
International
International Geriatric Radiotherapy Group
Immunotherapy and Radiotherapy for Older Cancer Patients during the COVID-19 Era: Proposed Paradigm by the International Geriatric Radiotherapy Group
Date: 30-Mar-2020
Audience: Radiation oncologists and medical oncologists
Purpose: Recommendations on how to manage immunotherapy and radiotherapy for older cancer patients during the COVID-19 pandemic.
[/accordion]